Eric C Bartee

Title: Eric C Bartee: Innovator in Cancer Treatment

Introduction

Eric C Bartee is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 2 patents, Bartee's work focuses on improving the outcomes for patients receiving grafts comprising hematopoietic cells.

Latest Patents

Bartee's latest patents include a method for treating or preventing graft versus host disease (GVHD) using Myxoma Virus. The first patent describes a method that involves contacting the graft ex vivo with an effective amount of Myxoma Virus to inhibit the proliferation of T lymphocytes in the graft. This process aims to treat or prevent GVHD in the host subject after the graft infusion. The second patent reiterates this method, emphasizing the importance of the Myxoma Virus in enhancing the safety and efficacy of graft transplants.

Career Highlights

Eric C Bartee is affiliated with the University of Florida Research Foundation, Incorporated. His work has been instrumental in advancing the understanding and treatment of GVHD, a significant complication in patients undergoing hematopoietic cell transplants. His innovative approaches have the potential to improve patient outcomes and reduce the risks associated with graft procedures.

Collaborations

Bartee has collaborated with notable colleagues, including Douglas Grant McFadden and Christopher R Cogle. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of cancer treatment.

Conclusion

Eric C Bartee's contributions to cancer treatment through his patented methods demonstrate his commitment to improving patient care. His innovative approaches in utilizing Myxoma Virus for treating GVHD highlight the potential for advancements in medical science.